| abstract |
The present invention relates to a novel monoclonal antibody that specifically binds to delta-like ligand 4 (DLL4), specifically to a human delta-like ligand 4, and specifically binds to a delta-like ligand 4 and a Notch receptor A polynucleotide encoding the monoclonal antibody, an expression vector comprising the polynucleotide, a transformant containing the expression vector, a method for producing the monoclonal antibody, a method for producing the monoclonal antibody A composition for diagnosing cancer comprising the monoclonal antibody, a method for diagnosing cancer using the monoclonal antibody, and a method for preventing or treating an autoimmune disease including the monoclonal antibody To a pharmaceutical composition. |